SLNSW-LY2495655, an antimyostatin antibody, in pancreat...-TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

Full title: LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

Author/creator: Golan, Talia, Geva, Ravit, Richards, Donald, Madhusudan, Srinivasan, Lin, Boris Kin, Wang, Haofei Tiffany, Walgren, Richard A., Stemmer, Salomon M..

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

Language: English

Formats: Articles

Publishers: Germany: John Wiley & Sons, Inc

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

    Share

    LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

    LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

    Full title

    LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

    Author / Creator

    Golan, Talia ; Geva, Ravit ; Richards, Donald ; Madhusudan, Srinivasan ; Lin, Boris Kin ; Wang, Haofei Tiffany ; Walgren, Richard A. ; Stemmer, Salomon M.

    Publisher

    Germany: John Wiley & Sons, Inc

    Journal title

    Journal of cachexia, sarcopenia and muscle, 2018, Vol.9 (5), p.871-879

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Age Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Binomial distribution Cachexia Cancer therapies Chemotherapy Drug dosages Enrollments Female Gender Humans Male Medical prognosis Metastasis Middle Aged Muscle mass Musculoskeletal system Myostatin Neoplasm Staging Original Pancreatic cancer Pancreatic Neoplasms - diagnosis Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - mortality Patients Prognosis Retreatment Statistical analysis Studies Survival Analysis Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08dd0a4842b84ca2856eae3aecb137c3

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections